New England Companies Awarded for InnovationNew England Companies Awarded for Innovation
January 1, 2007
Carol Devellian of NMT Medical, a recipient of the 2nd Annual Nixon Peabody/Smith & Nephew Medical Device Innovation Award. Pictured with Devellian from left to right are Joseph Leghorn, Nixon Peabody; Paul O'Connor, Smith & Nephew; and Mark Speers, HealthAdvances.
Six New England firms have been recognized for groundbreaking technologies that have positively affected healthcare. Massachusetts's association for medical device companies, MassMEDIC, presented the honors, dubbed the Medical Device Innovations Awards, at its annual Medtech Investors Conference in November.
“These companies are being honored for their exceptional ingenuity and extraordinary work, which has resulted in invaluable contributions to patients and the medical industry around the world,” says Tom Sommer, president of MassMEDIC.
Four winners and two honorable mentions were presented in three areas: early-stage companies with less than $5 million in annual revenue, emerging companies with $5 million to $49 million in revenue, and established firms with $50 million or more in yearly revenue. The awards recognize products that have been developed and manufactured by the association's member companies.
Haemonetics Corp. (Braintree, MA) won in the established company category for its CardioPAT cardiovascular autotransfusion system. The device recycles a patient's red blood cells that are lost during and after cardiovascular surgery.
Zoll Medical Corp. (Chelmsford, MA) received an honorable mention as an established firm. The Zoll AED Plus treats cardiac arrest victims by guiding rescuers via a graphical interface.
The emerging company winner was Boston-based NMT Medical Inc. Its STARFlex is a catheter-based, minimally invasive septal repair implant that treats structural heart disease.
Insulet Corp. (Bedford, MA) and SuturTek Inc. (North Chelmsford, MA) were cowinners in the early-stage company category. Insulet's OmniPod insulin management system provides continuous subcutaneous insulin delivery and blood glucose monitoring with a tubeless, two-part system. SuturTek's 360° fascia closure device protects surgeons and other staff from needlestick injuries that can occur during suturing.
The innovation awards are sponsored by Smith & Nephew and Nixon Peabody LLP (Boston).
Copyright ©2007 Medical Device & Diagnostic Industry
About the Author(s)
You May Also Like